Latest Mesoblast News & Updates
See the latest news and media coverage for Mesoblast. We track all announcements, press releases, and industry mentions in real time, all in one place.
Commercial-stage biotechnology company developing mesenchymal lineage cell therapies
mesoblast.com- Headquarters
- Melbourne, Australia
- Founded year
- 2004
- Company type
- Public company
- Number of employees
- 100–200
Last updated
Latest news about Mesoblast
Company announcements
-
Mesoblast highlights pipeline depth at R&D Day
Discusses commercialization success in graft-versus-host disease, expansions into adult indications, and opportunities in back pain, heart failure, and pediatric inflammatory diseases.
-
Mesoblast reports Ryoncil net revenues of US$30.3m
Net operating cash spend improves to US$4.1 million for the quarter.
-
Mesoblast releases quarterly activities and cash flow report
Report issued on April 30, 2026. Available as PDF download.
-
Mesoblast achieves patient recruitment target in CLBP pivotal trial
Recruitment target is reached for the pivotal trial in chronic low back pain.
Media coverage
-
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million
Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW...
-
Mesoblast Ltd (MESO): Secure Exclusive Rights to a Vital Platform
Mesoblast Ltd (NASDAQ:MESO) is among the best Australian stocks to buy in 2026. On April 14, Mesoblast Ltd (NASDAQ:MESO) announced that it has secured exclusive...
-
Mesoblast completes enrollment in back pain therapy trial By Investing.com
Mesoblast Limited (NASDAQ:MESO; ASX:MSB) announced Monday that its Phase 3 clinical trial evaluating rexlemestrocel-L for chronic low back pain associated with degenerative disc disease has...
-
Mesoblast Issues 3.28 Million New Shares on Option Conversions
Detailed price information for Mesoblast Ltd Ord (MEOBF) from The Globe and Mail including charting and trades.
Track Mesoblast and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Mesoblast competitors & trending companies
Browse news for competitors to Mesoblast and other trending companies.
NextCell Pharma
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove